Immediate Impact

3 by Nobel laureates 52 standout
Sub-graph 1 of 22

Citing Papers

Fluorescent Probes for Disease Diagnosis
2024 Standout
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer
2023 Standout
5 intermediate papers

Works of William Hyman being referenced

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
2009
Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer
2006

Author Peers

Author Last Decade Papers Cites
William Hyman 749 176 70 471 21 1.0k
F J Cummings 683 156 103 295 34 1.2k
Anne Moore 751 142 123 387 30 1.2k
Mary Cianfrocca 847 236 96 518 31 1.3k
Chantal Bernard-Marty 837 242 65 434 22 1.2k
Fernando Lara-Medina 464 189 57 397 38 858
M Hunt 589 266 80 157 20 991
J J Costanzi 635 281 131 268 36 1.2k
Margot J. Burnell 635 252 99 414 31 1.1k
Reginald P. Pugh 578 269 116 219 34 1.1k
Mariantonietta Colozza 999 298 48 466 36 1.4k

All Works

Loading papers...

Rankless by CCL
2026